You can buy or sell VBI Vaccines and other stocks, options, ETFs, and crypto commission-free!
VBI Vaccines, Inc. operates as a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. The firm offers offers development programs, HBV Therapeutic, Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Prophylaxis. Read More Its eVLP Platform technology allows for the development of enveloped virus-like particle eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Associated PressMar 18
VBI Vaccines to Present at the Oppenheimer 29th Annual Healthcare Conference
CAMBRIDGE, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that Nell Beattie, Chief Business Officer, will present at the Oppenheimer 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 9:10 AM ET in New York City. Details of the event are as follows: Oppenheimer 29th Annual Healthcare ConferenceDate: Wednesday, March 20,...
Expected Apr 30, Pre-Market